As of December 2024, Avalo Therapeutics has a market cap of $7.44M. This makes Avalo Therapeutics the world's 31838th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.90M | -46.48% |
2023 | $7.29M | -99.25% |
2022 | $969.63M | -75.29% |
2021 | $3.92B | -35.61% |
2020 | $6.09B | -51.02% |
2019 | $12.44B | 66.87% |
2018 | $7.46B | 0.94% |
2017 | $7.39B | 263.64% |
2016 | $2.03B | -73.73% |
2015 | $7.73B | - |